According to ORIC Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$2.92. In 2022 the company made an earnings per share (EPS) of -$3.02 a decrease over its 2021 EPS that were of -$2.78.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.98 | -1.21% |
2022 | -$3.02 | 8.7% |
2021 | -$2.78 | -17.6% |
2020 | -$3.37 | 78.87% |
2019 | -$1.88 |